You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

Article metrics

Article menu

Download PDFPDF

Hypothesis
Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

 

Online download statistics by month:

Online download statistics by month: April 2022 to July 2025

AbstractFullPdf
Apr 2022447466173
May 2022204213175
Jun 202216316759
Jul 202214815351
Aug 202216617145
Sep 202218018346
Oct 202218523560
Nov 202216216451
Dec 202211411929
Jan 202315215244
Feb 202313914239
Mar 202313013274
Apr 2023888946
May 2023818130
Jun 202310410426
Jul 202314414434
Aug 202316716939
Sep 202317417542
Oct 202315115437
Nov 2023868826
Dec 2023798037
Jan 2024434429
Feb 2024868635
Mar 2024169170106
Apr 2024858646
May 2024899136
Jun 2024929350
Jul 2024888932
Aug 2024404096
Sep 2024595923
Oct 2024656533
Nov 2024585923
Dec 20249710132
Jan 202511511666
Feb 2025909048
Mar 202512312568
Apr 202514514651
May 2025828229
Jun 2025545516
Jul 2025110
Total484549791982